Company / Current Liabilities per Share
Cyclerion Therapeutics, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.35
FY2025
5-year range
$0.18 / $0.96
FY2021-FY2025
Trend
-58.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.96 to $0.35 over the past 2 years.
Based on SEC 10-K filings.
0.35 in FY2025 with a 5-year CAGR of -10.5%.
Improved from $0.96 to $0.35 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +26.2%
- 5-Year CAGR
- -10.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 58.1% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.35 | -58.1% |
| FY2024 | $0.84 | -12.1% |
| FY2023 | $0.96 | +445.6% |
| FY2022 | $0.18 | -51.8% |
| FY2021 | $0.36 | -40.6% |
| FY2020 | $0.61 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026